BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26838212)

  • 1. Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?
    Lutfallah AA; Kourie HR; Eid R; Farhat F; Ghosn M; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(1):215-7. PubMed ID: 26838212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic lymphocytic leukemia].
    Maurer C; Hallek M
    Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia in India--a clinico-hematological profile.
    Agrawal N; Naithani R; Mahapatra M; Panigrahi I; Kumar R; Pati HP; Saxena R; Choudhary VP
    Hematology; 2007 Jun; 12(3):229-33. PubMed ID: 17558698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of chronic lymphocytic leukemia at a single centre over a 24-year period: prognostic factors for survival.
    Karmiris T; Rohatiner AZ; Love S; Carter M; Ganjoo RK; Amess J; Norton AJ; Lister TA
    Hematol Oncol; 1994; 12(1):29-39. PubMed ID: 7515019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic lymphocytic leukemia--the old and the new].
    Korte W; Cogliatti S
    Ther Umsch; 2004 Feb; 61(2):151-6. PubMed ID: 15018398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?
    Visco C; Cortelezzi A; Moretta F; Falisi E; Maura F; Finotto S; Barcellini W; Ambrosetti A; Neri A; Ruggeri M; Rodeghiero F
    Leuk Lymphoma; 2014 Jun; 55(6):1261-5. PubMed ID: 24047107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis related to staging systems for chronic lymphocytic leukemia.
    de Faria JR; de Oliveira JS; Delbone de Faria RM; Silva MR; Goihman S; Yamamoto M; Kerbauy J
    Sao Paulo Med J; 2000 Jul; 118(4):83-8. PubMed ID: 10887382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
    Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
    J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of younger versus older B-cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases.
    Molica S; Brugiatelli M; Callea V; Morabito F; Levato D; Nobile F; Alberti A
    Eur J Haematol; 1994 Apr; 52(4):216-21. PubMed ID: 8005231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-CLL in PLL transformation associated with hypercalcemia.
    Lerner D; Esteves C; De Oliveira MS
    Leuk Lymphoma; 1994 Jan; 12(3-4):321-5. PubMed ID: 8167564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S; De Rossi G; Luciani M; Levato D
    Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of CD200 in the bone marrow of chronic lymphocytic leukemia patients and its correlations with clinical prognosis].
    Wang X; Zhang Z; Liu Y; Wang L; Yuan H; Xie P; Qu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jan; 30(1):75-8. PubMed ID: 24405602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.
    Keating MJ; O'Brien S; Albitar M; Lerner S; Plunkett W; Giles F; Andreeff M; Cortes J; Faderl S; Thomas D; Koller C; Wierda W; Detry MA; Lynn A; Kantarjian H
    J Clin Oncol; 2005 Jun; 23(18):4079-88. PubMed ID: 15767648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
    Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
    Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia.
    Weiss MA; Maslak PG; Jurcic JG; Scheinberg DA; Aliff TB; Lamanna N; Frankel SR; Kossman SE; Horgan D
    J Clin Oncol; 2003 Apr; 21(7):1278-84. PubMed ID: 12663715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia.
    Frankel AE; Fleming DR; Hall PD; Powell BL; Black JH; Leftwich C; Gartenhaus R
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3555-61. PubMed ID: 14506141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5 negative lymphocytosis mimicking typical B-chronic lymphocytic leukaemia. Description of 26 cases.
    De Rossi G; Mauro FR; Lo Coco F; Caruso R; Niscola P; Pasqualetti D; Mandelli F
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):451-5. PubMed ID: 7692397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical efficacy and safety of chemoimmunotherapy with rituximab,fludarabine and cyclophosphamide for chronic lymphocytic leukemia].
    Li F; Yi SH; Yu Z; Xing LJ; Xu Y; Qi JY; Zhao YZ; Li ZJ; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):383-8. PubMed ID: 23688746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.